Syngeneic Stem Cell Transplantation

A procedure in which a patient receives blood-forming stem cells (cells from which all blood cells develop) donated by his or her healthy identical… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-2016
01219802016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND Transplantation of allogeneic mesenchymal stromal cells (MSCs) is a promising treatment for heart failure. We have… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
2009
2009
From March 1991 through 31st December 2007, 2042 patients underwent stem cell transplantation at the Hematology-Oncology and Stem… (More)
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
2009
2009
Plasma cell leukemia (PCL) is a rare variant of multiple myeloma, which is very aggressive and resistant to chemotherapy. We… (More)
  • figure 1
Is this relevant?
2009
2009
BACKGROUND Non adherent bone marrow derived cells (NA-BMCs) have recently been described to give rise to multiple mesenchymal… (More)
Is this relevant?
2008
2008
Stem cell research still remains one of the most controversial fields of science today on account cell plasticity and its… (More)
Is this relevant?
2005
2005
BACKGROUND Immunoablative therapy combined with haematopoietic stem cell transplantation (SCT) is a possible treatment for… (More)
  • figure 2
Is this relevant?
2004
2004
Summary:Severe graft-versus-host disease (GvHD) refractory to corticosteroids responds poorly to experimental treatment and is… (More)
Is this relevant?
2002
2002
We assessed long-term outcome in 155 patients who had undergone an allogeneic/syngeneic stem cell transplant (SCT) and were in… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 4
Is this relevant?
2002
2002
Dendritic cell (DC) vaccination represents an interesting immunotherapeutic option in the treatment of several malignancies. In… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
Review
1998
Review
1998
A 35-year-old man with non-Hodgkin's lymphoma (NHL) (follicular small cleaved, B cell, stage IVB) received double myeloablative… (More)
Is this relevant?